Cell Survival Pathways as Potential Targets in Breast Cancer [ 2015 - ]

Research Grant

Researchers: Dr James Whittle (Principal investigator)

Brief description Cancer cells are characterised by their capacity for relentless growth, survival and evasion of cell death. This proposal will use patient derived xenograft models of primary breast cancer to test the hypothesis that addition of BH3-mimetics could improve response to anti-HER2 therapy. This technique involves transplantation of patient tumours into immune-compromised mice. This represents a useful method for testing new agents.

Funding Amount $120,671.00

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship